Liminatus Pharma Stock (NASDAQ:LIMN)
Previous Close
$3.02
52W Range
$2.53 - $33.66
50D Avg
$7.35
200D Avg
$8.33
Market Cap
$74.70M
Avg Vol (3M)
$1.28M
Beta
0.52
Div Yield
-
LIMN Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.